ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-β1/ALK5/Smad2 pathway.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Transforming growth factor-β1 (TGF-β1) is implicated in regulating endothelial nitric oxide synthase (eNOS) in endothelial cells.
• ZNF580, a C2H2 zinc-finger nuclear transcription factor, is a novel factor with potential roles in TGF-β1 signaling.
• Understanding the interplay between ZNF580, TGF-β1, and eNOS is crucial for vascular biology.

Purpose of the Study:

• To investigate whether ZNF580 mediates eNOS expression.
• To determine ZNF580's role in endothelial cell migration and proliferation.
• To elucidate the involvement of the TGF-β1/Smad2/ZNF580/eNOS signaling pathway.

Main Methods:

• ZNF580 and eNOS expression were modulated (overexpression/downexpression) in EAhy926 cells.
• TGF-β1 treatment was applied in concentration- and time-dependent manners.
• The effect of ALK5 inhibitor SB431542 on TGF-β1-induced changes was assessed.
• Endothelial cell growth and mobility assays were performed.

Main Results:

• ZNF580 overexpression enhanced eNOS expression, while downexpression decreased it.
• TGF-β1 downregulated both ZNF580 and eNOS at mRNA and protein levels.
• The ALK5 inhibitor SB431542 blocked TGF-β1-induced downregulation of ZNF580 and eNOS.
• ZNF580 overexpression counteracted TGF-β1's inhibitory effects on cell growth and migration.

Conclusions:

• ZNF580 mediates eNOS expression in endothelial cells.
• ZNF580 plays a significant role in endothelial cell migration and proliferation.
• The TGF-β1/ALK5/Smad2/ZNF580/eNOS pathway is critical for vascular endothelial cell function.